BamSEC and AlphaSense Join Forces
Learn More

Upstream Bio Inc. – Material Contracts

NASDAQ: UPB    
Share price (6/23/26): $6.32    
Market cap (6/23/26): $344 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.7
from 10-K 3 pages Upstream Bio, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.20
from S-1/A 6 pages March 11, 2024 Michael Gray Re: Employment Offer Dear Mike: I Am Pleased to Confirm the Below Terms of Your Employment With Upstream Bio, Inc. (The “Company”) as Set Forth Below (This “Agreement”)
12/34/56
EX-10.19
from S-1/A 8 pages March 27, 2024 E. Rand Sutherland, MD, Mph Re: Employment Offer Dear Rand: I Am Pleased to Confirm the Below Terms of Your Employment With Upstream Bio, Inc. (The “Company”) as Set Forth Below (This “Agreement”)
12/34/56
EX-10.7
from S-1/A 3 pages Upstream Bio, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 34 pages Upstream Bio, Inc. Form of Employee Director / Officer Indemnification Agreement
12/34/56
EX-10.3
from S-1/A 10 pages Upstream Bio, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 41 pages Upstream Bio, Inc. 2024 Stock Option and Incentive Plan
12/34/56
EX-10.18
from S-1 79 pages Waltham Woods Corporate Center 890 Winter Street Waltham, Massachusetts Lease Dated July 3, 2024
12/34/56
EX-10.17
from S-1 99 pages Sublease Unit No. 3 of the Totten Pond Office Park Condominium, 460 Totten Pond Road, Waltham, Massachusetts
12/34/56
EX-10.16
from S-1 22 pages License Agreement
12/34/56
EX-10.15
from S-1 27 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Licence Agreement Between Lonza Sales AG and Upstream Bio, Inc. Index
12/34/56
EX-10.14
from S-1 31 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement
12/34/56
EX-10.13
from S-1 5 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Letter Agreement
12/34/56
EX-10.12
from S-1 43 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Asset Purchase Agreement by and Between Astellas Pharma Inc. and Upstream Bio, Inc. Dated as of October 14, 2021
12/34/56
EX-10.11
from S-1 9 pages Employment Agreement
12/34/56
EX-10.10
from S-1 10 pages February 26, 2024 Jen Beachell Dear Jen: Consistent With Our Recent Discussions, This Document Sets Forth the Details Relating to Your Transition From Employment With Upstream Bio, Inc. (“Upstream” or “The Company”). We Sincerely Appreciate Your Contributions to the Company and We Look Forward to a Productive and Collaborative Transition
12/34/56
EX-10.9
from S-1 10 pages March 13, 2024 Samantha Truex Dear Sam: Re: Severance Agreement This Document Sets Forth the Details Relating to Your Transition From Employment With Upstream Bio, Inc. (“Upstream” or “The Company”)
12/34/56
EX-10.8
from S-1 7 pages Upstream Bio, Inc. Compensation Recovery Policy Adopted as of August 19, 2024
12/34/56
EX-10.6
from S-1 11 pages Upstream Bio, Inc. Executive Severance Plan
12/34/56
EX-10.5
from S-1 3 pages Upstream Bio, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56